Commencez
priceissupreme

AuroPharma Simple Analysis Bullsih

Long
AUROBINDO PHARMA (NSE:AUROPHARMA)  
priceissupreme Mis à jour   
NSE:AUROPHARMA   AUROBINDO PHARMA
Trend Analysis Chart Patterns priceaction priceactionanalysis price-action
8
0
trendanalysis chartpattern priceaction priceactionanalysis price-action
AUROPHARMA is in an Up-Trend making HHs and HLs and I am expecting it to continue the Up-Trend.

It has just tested a Trendline and has a good Trap Zone so, expect it to give 5% ROI or 2:1 RR trade from here.
Trade fermée: cible de profit atteinte:
A Nice 2:1 Reward to Risk with a 6.54% Return on Investment.

Simple Analysis Rocks!

Idées en relation

priceissupreme
Metropolis Simple Price Action Analysis
priceissupreme
VEDL Simple Price Action Analysis
priceissupreme
Bank Nifty Simple Analysis
priceissupreme
TataMotors Simple Price-Action Analysis
priceissupreme
Reliance Simple Price Action Analysis
priceissupreme
NMDC Simple Price Action Analysis
priceissupreme
LICHSGFIN Simple Price Action Analysis Bullish
priceissupreme
PEL Simple Price Action Analysis Bullish
priceissupreme
Bajaj-Auto Simple Price Action Analysis Bullish
priceissupreme
Heromotoco Simple Price action Analysis Bullish
priceissupreme
Axis Bank Simple Price Action Analysis Bullish
priceissupreme
Zomato Simple Analysis Bullish
priceissupreme
Bank of Baroda Simple Analysis Bullish
priceissupreme
Wipro Simple Price Action Trend Analysis Bullish
priceissupreme
Anupam Rasayan Simple Price Action Analysis Bullish
priceissupreme
Titan Simple Analysis Bullish
priceissupreme
Tech Mahindra Simple Analysis Bullish
priceissupreme
SunTv Simple Analysis Bullish
priceissupreme
PNB a Simple Analysis - Bullish
priceissupreme
Hindalco Simple Trend Analysis Bullish
Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.